Table 1.
Baseline patients characteristics.
| Patients—n | n = 167 |
|---|---|
| Age (mean ± SD), years | 62.2 ± 14.2 |
| Sex, Male/Female—n | 77/90 |
| ASA score 1/2/3—n | 77/57/33 |
| Antiplatelet agent—n (%) | 17 (10.2) |
| Anticoagulation (VKA/DOA)—n (%) | 11 (6.6) |
| Hereditary predisposition syndrome—n (%) | 49 (29.3) |
| FAP | 34 (20.4) |
| Lynch syndrome | 2 (1.2) |
| MUTYH polyposis | 6 (3.6) |
| Juvenile polyposis | 1 (0.6) |
| Peutz-Jeghers syndrome | 3 (1.8) |
| Sporadic—n (%) | 118 (70.7) |
| Concurrent colonic adenoma/Colonoscopy—n (%) | 83/106 (78.3%) |
| Hereditary predisposition syndrome | 44/48 (91.7%) |
| Sporadic | 39/58 (67.2%) |
VKA: Vitamin K antagonist; DOA: Direct oral anticoagulant; n: number; SD: standard deviation; ASA: American society of anesthesiologists; FAP: Familial adenomatous polyposis; D1: First duodenum; D2 Second duodenum.